Treatment outcome of locally advanced stage IIIA/B lung cancer;Vietiškai išplitusio IIIA/B stadijos plaučių vėžio gydymo rezultatai

Medicina

Volumn 45, Issue 6, 2009, Pages 452-459

  Cicenas, Saulius ^a,b   Žaliene, Aurelija ^a   Atkočius, Vydmantas ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

^b sporto medicinos ir slaugos institutas   (Lithuania)

Author keywords

Morphology; Non small cell lung cancer; Stages; Statistical analysis; Survival; Treatment methods

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; AGED; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LARGE CELL CARCINOMA; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; PATHOLOGY; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; THORACOTOMY; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PALLIATIVE CARE; RADIOTHERAPY DOSAGE; THORACOTOMY; TREATMENT OUTCOME;

EID: 70349382897     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina45060059     Document Type: Article

References (13)

1. Jeremic B, Milicic B, Acimovic L, Milisavljevic S. Concurrent hyperfractionated radiotherapy and low-dose daily Carboplatin and Paclitaxel in patients with stage III nonsmall-cell lung cancer: long-term results of phase II study. J Clin Oncol 2005;23 (6):1144-1151.
2. Hoang T, Xu R, Schiller JH, Bonomi P, Johnson DH. Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on Eastern Cooperative Oncology Group data. J Clin Oncol 2005;23(1):175-83.
3. Stinchcombe TE, Fried D, Morris DE, Socinski MA. Combined modality therapy for stage III non-small cell lung cancer. J Oncologist 2006;11(7):809-23.
4. Plieskienė A, Juozaitytė E, Inčiūra A, Jaruševičius L, Mažuolis D, Sakalauskas R. Sergančiu{ogonek}ju{ogonek} plaučiu{ogonek} vėžiu prognoziniu{ogonek} veiksniu{ogonek} itaka gyvenimo trukmei. (Influence of prognostic factors on the survival of lung cancer patients.) Medicina (Kaunas) 2003;39(3):278-85.
5. Jackevičius A, Kurtinaitis J, Cicėnas S. Plaučiu{ogonek} vėžio gydymo rezultatai Lietuvos gydymo istaigose. (Results of lung cancer treatment in Lithuanian medical institutions.) Medicina (Kaunas) 2000;36(8):812-7.
6. Keller SM, Adak S, Wagner H, Herskovic A, Komaki R, Brooks BJ, et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II and IIIA non-small-cell lung cancer. New Eng J Med 2000;343(17): 1217-22.
7. Bollmann A, Blankenburg T, Haerting J, Kuss O, Schutte W, Dunst J, et al. Survival of patients in clinical stages I-IIIB of non-small-cell lung cancer treated with radiation therapyalone. Strahlenther Onkol 2004;180(8):488-96.
8. Sause W, Kolesar P, Taylor S, Livingston R, Komaki R, Johnson D, et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000;117:-358-64.
9. McKenne RJ, Movsas B, Shin DM, Khuri FR, Lee JS. Nonsmall-cell lung cancer, mesothelioma and thymoma. In: Pazdur R, Coia LR, Hoskins WJ, editors. Cancer management: a multidisciplinary approach. 6th ed. New York: PRR; 2002. p. 111-38.
10. Makitaro R. A population-based study of lung cancer and benign intrathoracic tumors. Department of Internal Medicine. Finland: Oulun Yliopisto; 1999.
11. Ulutin HC, Park Y. Preliminary results of radiotherapy with or without weekly paclitaxel in locally advanced non-smallcell lung cancer. J Cancer Res Clin Oncol 2003;129(1):52-6.
12. Norkus D, Juozaitytė E, Inčiūra A, Plieskienė A, Mažuolis D. Konformalios spindulinės terapijos itaka sergančiu{ogonek}ju{ogonek} plaučiu{ogonek} vėžiu gyvenimo trukmei. (The influence of conformal radiotherapy on survival of lung cancer patients.) Medicina (Kaunas) 2003;39(3):271-7.
13. Fournel P, Robinet G, Thomas P, Souquet PJ, Léna H, Vergnenégre A, et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study. J Clin Oncol 2005;23(25):5910-7